The American Association of Pharmaceutical Scientists (AAPS) has unveiled a transformative agenda for its 2026 PharmSci 360 conference, slated for…
Read More
The decline in United States drug overdose deaths is not driven by increased naloxone use according to new research
The landscape of the American opioid crisis shifted dramatically between mid-2023 and the end of 2025, a period defined by…
Read More
A plate of spaghetti: Talus Bio boasts 5,000-fold faster drug screening by skipping protein folding
The landscape of modern pharmaceutical research has been fundamentally altered by the advent of protein structure prediction tools, most notably…
Read More
Egypt Reforms Obsolete Pharmaceutical Pricing Framework to Revitalize Domestic Healthcare Sector and Secure Essential Drug Supplies
Egypt has officially undertaken a comprehensive overhaul of its decades-old pharmaceutical pricing framework, a decisive policy shift designed to resolve…
Read More
INmune Bio and Quantum Computing Inc. Join Forces in Milestone Partnership to Accelerate Drug Discovery for XPro Using Advanced Quantum Technology
Biotechnology innovator INmune Bio has entered into a landmark strategic partnership with Quantum Computing Inc. (QCi), marking QCi’s first-ever commercial…
Read More
FDA Unveils Rare Disease Framework Initiative to Accelerate Novel Therapies and Streamline Drug Development
The United States Food and Drug Administration (FDA) has officially rolled out the Rare Disease Framework Initiative, a sweeping regulatory…
Read More
The oral exposure challenge in PROTACs: What drug developers need to solve early
Proteolysis Targeting Chimera (PROTAC) technology has transitioned from a theoretical breakthrough in chemical biology to a validated clinical reality. In…
Read More
2026 PharmSci 360 adds tracks on research credibility and post-animal drug development
The American Association of Pharmaceutical Scientists (AAPS) has announced a significant evolution for its flagship 2026 PharmSci 360 conference, set…
Read More
A plate of spaghetti: Talus Bio boasts 5,000-fold faster drug screening by skipping protein folding
The pharmaceutical industry has long been defined by the pursuit of the "druggable" genome—a subset of proteins whose stable, pocketed…
Read More
An experimental drug kills fat cells, rather than shrinking them
The Biological Mechanism: Targeting Cell Death To understand the significance of this development, one must distinguish between the two primary…
Read More
